EverHint – Dip Bounce V2 (Reclaim) – Top 15 Signals for Sep 21, 2026
Excerpt: 15 signals (from 65 total). Healthcare leads (17). price range $9-$173. 3 with insider selling.
What This Signal Is
Production-ready dip-bounce strategy using reclaim pattern with Phase 2 market regime filters. Improved win rate from 40.42% (V1) to 50.18% (V2) with VIX and record high filters.
Entry Criteria:
- Minimum dip: 3.3% (open to intraday low)
- Minimum bounce: 1.0% from low
- Net change range: -2.0% to +0.3%
- Price above SMA(200)
- Minimum ADV: $40M
Holding period: 1-5 days | Risk level: Medium
Market Context
The broader market is displaying strong bullish momentum on September 21, 2026, with the Nasdaq leading gains at +2.26% and the S&P 500 advancing +1.49%. This broad-based rally, spanning growth-oriented and blue-chip indices alike, signals healthy risk appetite across market participants. For dip-bounce reclaim strategies, this environment is particularly constructive — rising tides tend to confirm technical reclaims more decisively, reducing the likelihood of false breakouts and increasing the probability that bounced levels hold as new support.
Volatility, as measured by the VIX at 14.80, remains subdued and essentially flat on the day. Low volatility environments compress intraday price swings, which can be a double-edged sword for dip-bounce setups: entries may require more patience as moves develop more gradually, but the reduced noise also means fewer stop-out whipsaws. Traders working these signals should expect measured, steady follow-through rather than explosive intraday momentum, and position sizing can reasonably reflect the lower risk environment.
Healthcare's emergence as the top sector among the 65 signals is a notable rotation cue. In a low-VIX, risk-on tape, defensive sectors like Healthcare don't typically lead — their presence here may suggest selective accumulation in higher-quality, less cyclically exposed names, or that specific technical setups within the sector have reached attractive reclaim levels independent of macro sentiment. This divergence is worth monitoring, as Healthcare leadership could indicate either early defensive rotation beneath the surface or simply idiosyncratic technical opportunity within an otherwise broadly bullish tape.
📊 Signals (15 of 65 total)
Ranked by dip magnitude (highest first)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | GRAL | GRAIL Inc. | Healthcare | $107.97 | 0.44 | — | $4.6B |
| 2 | MRNA | Moderna, Inc. | Healthcare | $172.94 | 0.42 | — | $68.6B |
| 3 | AXTI | AXT, Inc. | Technology | $79.93 | 0.41 | — | $4.1B |
| 4 | TWST | Twist Bioscience Corpo... | Healthcare | $165.83 | 0.35 | — | $10.3B |
| 5 | AUPH | Aurinia Pharmaceutical... | Healthcare | $16.61 | 0.27 | — | $2.1B |
| 6 | CDLR | Cadeler A/S | Industrials | $25.97 | 0.25 | — | $2.5B |
| 7 | MRK | Merck & Co., Inc. | Healthcare | $149.50 | 0.22 | — | $369.2B |
| 8 | BB | BlackBerry Limited | Technology | $8.53 | 0.21 | — | $5.0B |
| 9 | AMRX | Amneal Pharmaceuticals... | Healthcare | $20.16 | 0.20 | — | $6.4B |
| 10 | DAL | Delta Air Lines, Inc. | Industrials | $82.50 | 0.20 | — | $54.3B |
| 11 | ABSI | Absci Corporation | Healthcare | $9.82 | 0.19 | — | $1.7B |
| 12 | ABCL | AbCellera Biologics Inc. | Healthcare | $12.66 | 0.19 | — | $3.9B |
| 13 | HST | Host Hotels & Resorts,... | Real Estate | $22.31 | 0.18 | — | $15.3B |
| 14 | RUM | Rumble Inc. | Technology | $9.17 | 0.18 | — | $4.0B |
| 15 | FCEL | FuelCell Energy, Inc. | Industrials | $17.96 | 0.18 | — | $1.4B |
Field Notes
Sector concentration: Healthcare (17), Technology (15), Industrials (12)
Data coverage: 4.6% insider (7d), 0.0% congressional (30d), 0.0% earnings, 15.4% news (7d)
Recent Headlines
BB (BlackBerry Limited)
- BlackBerry Climbs 5% on Cramer Buy Call Ahead of Earnings; Aptiv Inches Higher, Mobileye Sits Tight
DAL (Delta Air Lines, Inc.)
- Airline Stocks Unbothered by Ground Stop Delays: UAL Up 5%
- Delta Air Lines Boosts LAX Presence With Biggest-Ever Schedule
GRAL (GRAIL Inc.)
- GRAIL: Stock Surges As Market Digests FDA Briefing Docs - I Broadly Concur (Rating Upgrade)
MRNA (Moderna, Inc.)
- Moderna Stock Is Soaring: What's Going On?
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (17 signals) suggests sector-specific rotation. 3 signals showing insider selling warrant caution.
Trading tips for this strategy:
- Entry timing: Consider entering on next-day weakness or at previous day's close level
- Position sizing: Start small (1-2% of portfolio per signal)
- Stop loss: Below today's low (tight stops for mean reversion)
- Take profit: 3-5% bounce target, or previous day's high
- Time stop: Exit if no bounce in 1-3 days
Risk warning: Mean reversion can fail in strong downtrends - check broader market context
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.